DAE HWA Pharmaceutical Co. Ltd (067080) — Capital Reinvestment Ratio
DAE HWA Pharmaceutical Co. Ltd (067080) has a Capital Reinvestment Ratio of 1.09x as of March 2026, meaning it reinvests 1% of its operating cash flow (₩314.63 Million) in capital expenditures (₩343.17 Million). Check 067080 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
DAE HWA Pharmaceutical Co. Ltd Capital Reinvestment Ratio (2011–2025)
This chart tracks DAE HWA Pharmaceutical Co. Ltd's Capital Reinvestment Ratio across 13 annual periods. For the full cash flow conversion analysis, see DAE HWA Pharmaceutical Co. Ltd cash flow conversion.
Annual Capital Reinvestment Ratio for DAE HWA Pharmaceutical Co. Ltd (2011–2025)
Year-by-year Capital Reinvestment Ratio for DAE HWA Pharmaceutical Co. Ltd from 2011 to 2025. See how much free cash does DAE HWA Pharmaceutical Co. Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.87x | ₩5.43 Billion | ₩4.73 Billion | ▼ -13.2% |
| 2024 | 1.00x | ₩6.13 Billion | ₩6.14 Billion | ▼ -74.7% |
| 2022 | 3.97x | ₩8.05 Billion | ₩31.94 Billion | ▲ +188.1% |
| 2021 | 1.38x | ₩10.45 Billion | ₩14.40 Billion | ▼ -61.5% |
| 2020 | 3.58x | ₩2.90 Billion | ₩10.38 Billion | ▲ +680.2% |
| 2018 | 0.46x | ₩10.49 Billion | ₩4.81 Billion | ▼ -30.8% |
| 2017 | 0.66x | ₩10.94 Billion | ₩7.26 Billion | ▲ +44.7% |
| 2016 | 0.46x | ₩8.79 Billion | ₩4.03 Billion | ▼ -75.9% |
| 2015 | 1.90x | ₩2.43 Billion | ₩4.62 Billion | ▲ +307.6% |
| 2014 | 0.47x | ₩6.18 Billion | ₩2.88 Billion | ▲ +434.8% |
| 2013 | 0.09x | ₩13.57 Billion | ₩1.18 Billion | ▼ -62.9% |
| 2012 | 0.23x | ₩5.77 Billion | ₩1.36 Billion | ▼ -91.3% |
| 2011 | 2.71x | ₩3.43 Billion | ₩9.31 Billion | — |